Literature DB >> 2696553

Clinical and photobiological characteristics of xeroderma pigmentosum complementation group F: a review of cases from Japan.

K Yamamura1, M Ichihashi, T Hiramoto, M Ogoshi, K Nishioka, Y Fujiwara.   

Abstract

A 61-year-old female patient with xeroderma pigmentosum (XP), registered as XP46KO, was assigned to complementation group F by the cell fusion-complementation method. The XP46KO fibroblasts in culture exhibited a defective DNA repair capacity of 10-15% unscheduled DNA synthesis and a 3-fold sensitivity to the lethal effect of 254 nm ultraviolet light compared with normal cells. The patient had mild clinical symptoms consisting of numerous pigmented freckles and a small number of seborrheic keratosis-like papules. She had no skin cancers in the sun-exposed areas of the skin and so far no neurological abnormalities. A review of 11 Japanese group F patients revealed very mild skin symptoms with no ocular or neuro-psychiatric abnormalities. Single skin cancers occurred in only 3 of the 11 patients with an average age of 52 years for their first skin malignancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2696553     DOI: 10.1111/j.1365-2133.1989.tb15514.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.

Authors:  Siobhán Q Gregg; Andria Rasile Robinson; Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2011-05-25

2.  SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.

Authors:  Huimin Zhang; Zhen Chen; Yin Ye; Zu Ye; Dan Cao; Yun Xiong; Mrinal Srivastava; Xu Feng; Mengfan Tang; Chao Wang; John A Tainer; Junjie Chen
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

3.  The cerebro-morphological fingerprint of a progeroid syndrome: white matter changes correlate with neurological symptoms in xeroderma pigmentosum.

Authors:  Jan Kassubek; Anne-Dorte Sperfeld; Elmar H Pinkhardt; Alexander Unrath; Hans-Peter Müller; Karin Scharffetter-Kochanek; Albert C Ludolph; Mark Berneburg
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.